COVID-19 NOT SPREAD BY MOSQUITOES - A new study by Kansas State University researchers is the first to confirm that SARS-CoV-2 cannot be transmitted to people by mosquitoes. Stephen Higgs, associate vice president for research and director of the university’s Biosecurity Research Institute, or BRI, together with colleagues from the BRI and the College of Veterinary Medicine had the findings published by Scientific Reports. The article, “SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge,” details the study’s findings, which provide the first experimental investigation on the capacity of SARS-CoV-2, the virus that causes COVID-19 disease, to infect and be transmitted by mosquitoes. “While the World Health Organization has definitively stated that mosquitoes cannot transmit the virus, our study is the first to provide conclusive data supporting the theory,” said Higgs, Peine professor of biosecurity and university distinguished professor of diagnostic medicine and pathobiology. The study, which was done at the BRI, a biosecurity level-3 facility, ultimately found that the virus is unable to replicate in three common and widely distributed species of mosquitoes — Aedes aegypti, Aedes albopictus and Culex quinquefasciatus — and therefore cannot be transmitted to humans.“I am proud of the work we are doing at K-State to learn as much as we can about this and other dangerous pathogens,” said Higgs.

 

.....................................................................................................................................................

COVID-19 Not Spread By Mosquitoes

Scientific Inquirer

 

A new study by Kansas State University researchers is the first to confirm that SARS-CoV-2 cannot be transmitted to people by mosquitoes.

Stephen Higgs, associate vice president for research and director of the university’s Biosecurity Research Institute, or BRI, together with colleagues from the BRI and the College of Veterinary Medicine had the findings published by Scientific Reports.

The article, “SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge,” details the study’s findings, which provide the first experimental investigation on the capacity of SARS-CoV-2, the virus that causes COVID-19 disease, to infect and be transmitted by mosquitoes.

“While the World Health Organization has definitively stated that mosquitoes cannot transmit the virus, our study is the first to provide conclusive data supporting the theory,” said Higgs, Peine professor of biosecurity and university distinguished professor of diagnostic medicine and pathobiology.

The study, which was done at the BRI, a biosecurity level-3 facility, ultimately found that the virus is unable to replicate in three common and widely distributed species of mosquitoes — Aedes aegypti, Aedes albopictus and Culex quinquefasciatus — and therefore cannot be transmitted to humans.

“I am proud of the work we are doing at K-State to learn as much as we can about this and other dangerous pathogens,” said Higgs.

“This work was possible because of the unique capabilities of the BRI and the dedicated BRI and institutional staff.”

Colleagues involved with the study include Yan-Jang Huang, research assistant professor of diagnostic medicine and pathobiology; Dana Vanlandingham, professor of diagnostic medicine and pathobiology; Ashley Bilyeu and Haelea Sharp, research assistants in diagnostic medicine and pathobiology; and Susan Hettenbach, research assistant at the BRI.

Researchers at the BRI have completed four additional studies on COVID-19 since March and this is the first peer-reviewed publication based on SARS-CoV-2 experiments wholly conducted at K-State.

Research at the Biosecurity Research Institute has been ongoing with other animal pathogens that can be transmitted from animals to people, including Rift Valley fever and Japanese encephalitis, as well as diseases that could devastate America’s food supply, such as African swine fever and classical swine fever.

The research was in part supported by the National Bio and Agro-Defense Facility Transition Fund provided by the state of Kansas.

“We have remarkable talent and capabilities working within our research and training facility at the BRI,” said Peter Dorhout, K-State vice president for research.

“The BRI is one of the critical anchor facilities in the North Campus Corridor, which serves as our growing research and development space for private sector and government agency partnerships with K-State.”

The Scientific Inquirer is dedicated to exploring the junction where science and life meet, whether it’s in the lab or the studio or the diamond. There’s science everywhere and it’s amazing.

https://scientificinquirer.com/2020/07/17/covid-19-not-spread-by-mosquitoes-study/

DENGUE - Dengue fever is a severe, flu-like illness that affects infants, young children and adults but rarely causes death. The symptoms, following an incubation period of five to eight days, are fever, chills, and severe headache, pain in the joints, sweating, and prostration. Dengue hemorrhagic is a potentially lethal complication and is today a leading cause of childhood death in several Asian countries. It is characterized by high fever, haemorrhage, often enlargement of the liver, and in the most severe cases circulatory failure. Today, dengue is found in tropical and subtropical regions around the world, predominately in urban and per urban areas, where Aedes mosquitoes are prevalent. Globally there are an estimated 50-100 million cases of dengue fever each year.

..........................................................................................................................................................

Dengue

Lenntech

Dengue is an acute infectious disease caused by a virus and transmitted by the bite of the Aedes mosquito, also known as break bone fever and bone-crusher disease.

Dengue fever is a severe, flu-like illness that affects infants, young children and adults but rarely causes death.

The symptoms, following an incubation period of five to eight days, are fever, chills, and severe headache, pain in the joints, sweating, and prostration.

The clinical features vary according to the age of the patient.

Infants and young children may have a feverish illness with rash.

Older children and adults may have either a mild feverish illness, or the classical incapacitating disease with abrupt onset and high fever, severe headache, pain behind the eyes, muscle and joint pains and rash.

Dengue hemorrhagic is a potentially lethal complication and is today a leading cause of childhood death in several Asian countries.

It is characterized by high fever, haemorrhage, often enlargement of the liver, and in the most severe cases circulatory failure.

Today, dengue is found in tropical and subtropical regions around the world, predominately in urban and per urban areas, where Aedes mosquitoes are prevalent.

Globally there are an estimated 50-100 million cases of dengue fever each year.

Lenntech provides water treatment solutions for all type of applications, from domestic equipment to industrial turnkey plants up to 5000 m3/day.

Our wide range of technologies and extended know-how in all water-related sectors will guarantee you a cost-efficient solution meeting your water quality requirements.

Lenntech deals daily with clients from various origin: municipalities, water bottlers, hotels and resort requiring safe drinking water for their visitors, farmers needing specific irrigation water for their plants, but also industries like power plants, oil and gas, chemical factories, requiring specific process water for their equipment.

https://www.lenntech.com/library/diseases/dengue/dengue.htm